Background {#sec1}
==========

Progressive renal failure is a common scenario in clinical practice. In many cases, the cause is obvious. In some cases, however, the patient's history and clinical presentation may be misleading. We report here the case of a woman admitted for progressive renal failure with a history of hypertension, osteoporosis and recent therapy for breast cancer, presenting with significant hypercalcaemia, hyperphosphataemia and bicytopaenia. Further evaluation revealed an unexpected diagnosis.

Case report {#sec2}
===========

A 70-year-old woman with a history of hypertension and osteoporosis presented with progressive renal insufficiency, abnormal fatigue for several months and increasing shortness of breath during exercise. Five months previously, an invasive ductal breast carcinoma (pT2, pTis, pN0, cM0 and R0) had been diagnosed, and the patient underwent breast-conserving tumour resection, followed by adjuvant radiotherapy and treatment with a non-steroidal aromatase inhibitor. On admission, the patient appeared to be in a good general condition (weight 53 kg, height 168 cm and BMI 19 kg/m^2^) and seemed only slightly affected. Vital signs were normal (blood pressure 130/60 mmHg and heart rate 80 bpm), and physical examination was unremarkable. The patient's medication included letrozole, calcium and vitamin D~3~. Previous administration of alendronate had been stopped before admission. Laboratory testing showed impaired renal function with a creatinine of 297 μmol/L and an estimated glomerular filtration rate (GFR) of 14 mL/min/1.73 m^2^. Serum calcium level was significantly elevated (3.6 mmol/L) in the presence of slightly lowered serum albumin (31 g/dL). A blood count showed normocytic anaemia (haemoglobin 11,5 g/dL), leucocytopaenia (2840/μL) and a normal platelet count; a differential blood count revealed significant lymphocytopaenia (227/μL). Further biochemical tests demonstrated hyperphosphataemia (2.4 mmol/L) but normal values for parathyroid hormone and C-reactive protein. Urinalysis showed signs of prevailing tubulointerstitial nephritis with minor leucocyturia, predominant tubular proteinuria and mild haematuria.

A diagnostic work-up was performed to establish the cause of hypercalcaemia and bicytopaenia and to identify the underlying renal disease. A skeletal scintigraphy ruled out bone metastatic disease, and abdominal ultrasound did not show any isolated metastases or a tumour mass. Renal ultrasound demonstrated kidneys of normal size with hyperechoic parenchyma and hypoechoic pyramids as well as signs of nephrocalcinosis. Computed tomography of the chest revealed two new very small nodular lesions in both upper lobes; however, there was no notion of enlarged intrathoracic lymph nodes. Spirometric testing was within the normal range (FEV1 85%, VCin 99%, FEV1/VCin 90% and pO~2~ 84 mHg). Subsequent bronchoscopy showed a macroscopically normal bronchial system, and bronchoalveolar lavage did not reveal suspicious cells or any infectious pathogen but a lymphocytic cell profile with an elevated T4/T8 ratio of 5.5. A renal biopsy was performed: histopathology displayed a few moderate epithelioid cell granulomas with interstitial nephritis, slight nephrocalcinosis and moderate focal tubular atrophy, suggesting sarcoid nephropathy ([Figure 1](#fig1){ref-type="fig"}A and B). Bone marrow biopsy demonstrated impaired haematopoiesis with slight siderosis, moderate plasmocytosis and surprisingly also an epithelioid cell granuloma ([Figure 1](#fig1){ref-type="fig"}C), consistent---although non-specific---with manifestation of sarcoidosis. Immunophenotyping of the bone marrow revealed CD138/CD19-positive plasma cells, but no light chains or any other B- or T-cell clonal disease. Revision of a lymph node biopsy, previously performed for staging of the breast cancer, also revealed an epithelioid cell granuloma ([Figure 1](#fig1){ref-type="fig"}D). Further laboratory testing was negative for immunological antibodies, including antinuclear antibodies and c- and p-ANCAs, but showed elevated serum levels for angiotensin-converting enzyme (137 U/L, normal \< 52). Echocardiography demonstrated moderate left ventricular hypertrophy with normal systolic function and slight diastolic dysfunction.

![(**A**, **B**) Renal histology: A. Epithelioid cell granuloma (asterisk) with multinucleated giant cells, adjacent to a glomerulus (PAS staining); B. CD68 staining depicting macrophages, epithelioid cells and multinucleated giant cells (APAAP method); von Kossa staining demonstrated microcalcifications within the tubulointerstitium (not shown). (**C**) Bone marrow histology, depicting moderate plasmocytosis and a non-caseating granuloma (arrowheads). Ziehl--Neelsen staining was negative (not shown). (**D**) Lymph node histology obtained 5 months previously for breast cancer staging, demonstrating tumour-free sentinel lymph nodes and an epithelioid cell granuloma with giant cells (arrows).](sfq184fig1){#fig1}

Altogether, a diagnosis of sarcoidosis with renal, pulmonary, bone marrow and lymph node involvement was made, while cardiac manifestation was suspected. Treatment with prednisolone resulted in significantly improved renal function within several days, normalized calcium and phosphate values, and led to a haemoglobin and leucocyte count within the normal range. Follow-up studies 3 months later showed an almost normal serum creatinine level of 108 μmol/L with an estimated GFR of 46 mL/min/1.73 m^2^, a normalized ACE level and regressive pulmonary lesions.

Discussion {#sec3}
==========

Nephrocalcinosis is usually an incidental finding in ultrasound or CT imaging or in a renal biopsy specimen, and may both cause and sustain progressive renal insufficiency. Any disorder leading to high calcium levels and/or hypercalciuria may result in renal calcium deposition, thereby promoting nephrolithiasis or renal parenchymal damage with subsequent reduced renal function. Thus, nephrocalcinosis demands further evaluation with identification of the underlying cause to provide a therapeutic approach \[[@ref1]\].

In our patient, the combination of hypercalcaemia and a previous diagnosis of breast cancer initially suggested bone metastasis. However, an unremarkable skeletal scintigraphy did not support this idea. Primary hyperparathyroidism was ruled out by normal parathyroid hormone levels. Although calcium and vitamin D supplementation in association with renal insufficiency were consistent with vitamin D intoxication or milk-alkali syndrome as a possible cause for hypercalcaemia, stopping the medication did not normalize calcium homeostasis. Finally, other differential diagnoses had to be taken into account: since history, clinical presentation and biochemical findings were not compatible with Addison's disease, inflammatory bowel disease or thyreotoxicosis, sarcoidosis was considered the most likely cause.

Clinical manifestation and outcome of sarcoidosis are highly variable, and the diagnosis is often delayed \[[@ref2]\]. The typical primary manifestation is the lung, often associated with involvement of skin, eyes, and the reticuloendothelial or musculoloskeletal system. Infrequently, the heart, kidney and liver as well as endocrine and exocrine glands are affected \[[@ref3]\]. Bone marrow involvement is very rare but may be underdiagnosed \[[@ref4]\].

In our patient, the combination of hypercalcaemia, nephrocalcinosis and urinalysis was suspicious for sarcoid nephropathy, and renal biopsy established the diagnosis. Histopathological evidence of non-purulent destructive tubulointerstitial nephritis supported the diagnosis, with granulomatous infiltration being confirmative \[[@ref6]\]. Renal disease in sarcoidosis always requires intervention since lack of treatment may allow progression to chronic renal failure. In the present case, renal histology demonstrated not only calcinosis but also reversible tubular damage: administering corticosteroids reduced serum calcium levels and hypercalciuria, thereby preventing further renal damage and significantly improved kidney function. Unfortunately, renal involvement is usually steroid-dependent with a decline in kidney function when therapy is stopped \[[@ref8]\]. In the present case, this may only be determined with a longer follow-up.

Pulmonary infiltration and nodular lesions together with a high T4/T8 ratio in bronchoalveolar lavage and the absence of infection also pointed to sarcoidosis despite the lack of intrathoracic lymphadenopathy. However, the extent of pulmonary sarcoidosis would not have justified the corticosteroid treatment, and in the context of previously diagnosed breast cancer, metastatic disease could not be definitively ruled out. Since sarcoidosis may even mimic metastatic malignancy, histological evidence may be important \[[@ref9]\]. Eventually, a short-term follow-up with CT imaging was helpful to distinguish between both disease entities.

Surprisingly, bicytopaenia was shown to be the result of bone marrow sarcoidosis. With respect to previous breast cancer, bone marrow cancer infiltration may have been the most likely diagnosis; other differential diagnoses included myelodysplastic syndrome and renal anaemia. Surprisingly, bone marrow histology and phenotyping demonstrated an epithelioid cell granuloma and plasmocytosis consistent with sarcoidosis. Conceivably, bone marrow involvement is frequently underdiagnosed since diagnostic biopsy sites are most often intrapulmonary, based on the common clinical presentation \[[@ref5]\].

Of interest, retrospective analysis of the lymph node biopsies obtained a few months previously also revealed a non-caseating epithelioid cell granuloma. While epithelioid granulomas occasionally are a manifestation of a lymphoma \[[@ref11]\], the so-called sarcoid-like lesions are often described in association with various malignancies, such as melanoma, breast cancer or lung cancer \[[@ref12]\]. In the present case, the pathological changes probably reflected sarcoid manifestation in the reticuloendothelial system, mimicking metastatic disease \[[@ref9]\]. However, an association of sarcoidosis with cancer has been previously reported several times \[[@ref14]\].

Finally, an elevated serum ACE was supportive of the diagnosis: up to 75% of untreated patients have increased serum levels \[[@ref18]\]. Other disorders with granulomas in the kidney were excluded: the absence of c-ANCA antibodies or typical clinical signs as well as normal C-reactive protein made vasculitis, such as Wegener's granulomatosis, an unlikely diagnosis; specific stains in histology ruled out an infectious disease.
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